As shown in Figure 2A, the frequency of major subsets of NK cells, CD56brightCD16− cytokine-producing, and CD56dimCD16+ cytotoxic NK cells, as well as NKT-like CD3+CD56+ cells was unchanged in patients with COVID-19 compared to healthy controls, irrespective of the course of disease. This evidence concerns the gene NCAM1 and COVID-19.